Aurobindo Pharma to launch ₹800 crore buyback at ₹1,475 per share from April 23
Aurobindo Pharma Ltd on Tuesday (April 21) said it has submitted the Letter of Offer for its buyback of equity shares worth up to ₹800 crore through the tender offer route. The buyback covers up to 54.23 lakh fully paid-up equity shares of face value ₹1 each at a price of ₹1,475 per share, payable…
